TIS
Click for more information
0.00% 0.0¢ tissue therapies limited

Wednesday 24, page-27

  1. jockhock
    17 Posts.
    clock Created with Sketch.
    22/09/14
    23:03
    Post #: 14012484
    And there you have it.

    EMEA/H/D/002831), ((substance to be reviewed) insulin-like growth factor-i (igf-i) segment), (hard-to-heal wounds, primarily venous leg ulcers) List of Questions adopted on 23.01.2014. • List of Outstanding Issues: For adoption
    TIS Price at posting: 42.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Thrilling study results take Orthocell a step closer to FDA clearance
right-arrow Created with Sketch.
RMS Flicka Lake Project enters promising new era as highly encouraging results found
right-arrow Created with Sketch.
NEWS $6.2 million Government Grant secured by Hazer to progress technology commercialisation
right-arrow Created with Sketch.
NEWS Updated resource estimates soar for the Pepper Gold Deposit in Western Australia
right-arrow Created with Sketch.
USQ Expanded deep drilling gold program unveiled for Leonora flagship project
right-arrow Created with Sketch.
NEWS Peppermint looks to elevate AI and data transformation
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.